During the past decade, Yale Transplantation Center/Yale-New Haven Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale Transplantation Center/Yale-New Haven Hospital" #1 collaborator was "SurgiQuest, Inc." with 1 trials as a collaborator and "Veloxis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Yale Transplantation Center/Yale-New Haven Hospital" are "Kidney Transplant; Complications" (2 trials), "Alcoholic Liver Disease" (1 trials), "Pain" (1 trials) and "Skeletal Anomalies" (1 trials). Many other conditions were trialed in "Yale Transplantation Center/Yale-New Haven Hospital" in a lesser frequency.

Most popular intervention types in "Yale Transplantation Center/Yale-New Haven Hospital" are "Behavioral" (1 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Conventional pressure" (1 trials), "Tacrolimus, Extended Release, (Envarsus Xr)" (1 trials), "Text Message" (1 trials), "Valveless recirculating insufflation (VTI)" (1 trials) and "measurements to evaluate metabolic bone disease" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale Transplantation Center/Yale-New Haven Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Yale Transplantation Center/Yale-New Haven Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Yale Transplantation Center/Yale-New Haven Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale Transplantation Center/Yale-New Haven Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".